Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 1,326 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Validation Clear all

Conditions: Prostate Cancer (Diagnosis)
Interventions: HeLP TM; Device
Lead sponsor: Duke University; Other
Eligibility: 40 Years and older · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Keratoconjunctivitis Sicca
Interventions: Not listed
Lead sponsor: TearLab Corporation; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 314 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 6
States / cities: San Diego, California • Louisville, Kentucky • Chesterfield, Missouri + 3 more

Conditions: Risk Reduction Behavior
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older · Female only
Enrollment: 3,112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Balance Training, Breathing and Stretching Exercises; Other
Lead sponsor: Texas Woman's University; Other
Eligibility: 60 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 4
States / cities: Houston, Texas • Sugar Land, Texas • Webster, Texas

Conditions: Medication Compliance, Contraception, Self-Evaluation
Interventions: watch an instructional video; Behavioral
Lead sponsor: Tufts Medical Center; Other
Eligibility: Up to 19 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Gambling Addiction
Interventions: Kaihani Score; Diagnostic Test
Lead sponsor: Therapeutic Solutions International; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 30 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Oceanside, California

Conditions: Prostate Cancer
Interventions: Decipher® Testing; Other
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2026
U.S. locations: 3
States / cities: Bay Pines, Florida • Tampa, Florida

Conditions: Weight Management, Cardiovascular (CV) Risk, Metabolic and Nutritional Disorders
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy
Interventions: Not listed
Lead sponsor: Sotera Wireless, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Type2 Diabetes
Interventions: Abbott Freestyle Libre Pro, LifeStyle; Device · Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 70 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Glioblastoma, IDH1 Gene Mutation, IDH2 Gene Mutation, Low Grade Glioma, Malignant Glioma, Recurrent Glioblastoma, Recurrent WHO Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma, WHO Grade III Glioma
Interventions: PARP Inhibitor BGB-290, Temozolomide (TMZ); Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years to 39 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 11
States / cities: Los Angeles, California • San Francisco, California • New Haven, Connecticut + 8 more

Conditions: Infant Nutrition Disorders, Weight Loss, Postnatal Care, Premature Birth
Interventions: Woddle Smart Changing Pad; Device
Lead sponsor: Stan Kachnowski; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 3
States / cities: New York, New York • The Bronx, New York

Conditions: Obstructive Sleep Apnea, Down Syndrome
Interventions: Sleep study; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 2 Years to 17 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Liver Disease
Interventions: Fresh Frozen Plasma, Pre-Transfusion International Normalized Ratio (INR), Post-Transfusion International Normalized Ratio (INR); Biological · Diagnostic Test
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Eye Movement
Interventions: NeuraLight; Other
Lead sponsor: NeuraLight; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 2,000 participants
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Healthy Eyes
Interventions: DRI OCT Triton plus; Device
Lead sponsor: Topcon Medical Systems, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Oakland, New Jersey

Conditions: Prostate Cancer
Interventions: Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI); Other
Lead sponsor: University of California, San Diego; Other
Eligibility: Male only
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Arthropathy of Knee, Arthritis Knee, Arthritis, Degenerative
Interventions: Fitbit; Other
Lead sponsor: Benaroya Research Institute; Other
Eligibility: 18 Years to 100 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Colorectal Cancer
Interventions: MRD; Device
Lead sponsor: Exact Sciences Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 1,017 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 28
States / cities: Mission Hills, California • Torrance, California • Gainesville, Florida + 25 more

Conditions: Infiltration of Peripheral IV Therapy
Interventions: ivWatch Model 400 with SmartTouch Sensor, ivWatch Model 400 with Fiber Optic Sensor; Device
Lead sponsor: ivWatch, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Williamsburg, Virginia

Conditions: Duodenal Atresia
Interventions: Performance of laparoscopic duodenal atresia repair; Procedure
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 25 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Severe Sepsis
Interventions: Not listed
Lead sponsor: Bluejay Diagnostics, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Acton, Texas

Conditions: Anal High-Grade Squamous Intraepithelial Lesions
Interventions: Assessment of Health-Related Quality; Behavioral
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 35 Years and older
Enrollment: 406 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2023
U.S. locations: 4
States / cities: Evanston, Illinois • New York, New York

Conditions: Shoulder Adhesive Capsulitis, Knee Osteoarthritis
Interventions: ViFIVE Digital Care Progrma; Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Redwood City, California

Search by objective public record fields.

Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer

TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease

Self-Affirmation: Construct Validity

The Prescriptive Validity of a Novel Fall Risk Clinical Prediction Rule for People With COPD

Adolescent Subcutaneous (SQ) Injection Video Validation

Validation of Kaihani Score for Gambling Addiction

Validation Study on the Impact of Decipher® Testing - VANDAAM Study

Feasibility, Acceptability, and Validation of a User-friendly Diet Quality Tool in Adults From Ambulatory Nutrition Clinics

Accuracy of Continuous SpO2 Measurement in Adults

Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among North American Individuals With Newly Diagnosed Type 2 Diabetes

BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas

Feasibility and Validation of a Smart Changing Pad for Home Infant Weight Monitoring After Hospital Discharge

Validation of Sleep Questionnaires in the Down Syndrome Population

Prospective Validation of a Plasma Transfusion Dosing Algorithm in Patients With Chronic Liver Disease

Development and Validation of a Novel Eye-Tracking Software-based Platform to Extract Oculometric Measures

TopQ Cutoff Threshold Validation Study for DRI OCT Triton Plus

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

Validation of Consumer Activity Monitors in Postoperative Total Arthroplasty Patients

CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

ivWatch Sensor: Device Validation for Infiltrated Tissues

Validation of a Totally Synthetic High Fidelity Laparoscopic Duodenal Atresia (DA) Surgical Simulator

Symphony IL-6 Cutoff Validation Study for Patients at Risk of Severe Sepsis

Validation of a Health-Related Symptom Index for Persons Diagnosed With and Either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL)

Validity of AI in Treatment of the Musculoskeletal Conditions by Vifive